George Soros’s AnaptysBio ANAB Stock Holding History

George Soros’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-62,300	Closed	-$6.28M	–	222
2017 Q4	$6.28M	Buy	+62,300	New	+$4.59M	0.14%	98

Other funds holding ANAB

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

George Soros's ANAB Position: Q1 2018 in Review

George Soros sold out of AnaptysBio (ANAB) in Q1 2018, closing a stake of 62,300 shares — an estimated $6.28M sold.

George Soros first reported a position in ANAB in Q4 2017 and held it in 1 quarter. The position peaked at $6.28M in Q4 2017. 134 funds tracked by Wall St. Rank hold ANAB as of Q1 2018.

George Soros reported no remaining AnaptysBio position as of Q1 2018 after selling out during the quarter.
George Soros sold 62,300 AnaptysBio shares in Q1 2018, an estimated $6.28M.
George Soros first reported a position in AnaptysBio in Q4 2017 and held it in 1 quarter.
George Soros's AnaptysBio position peaked at $6.28M in Q4 2017.
134 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2018.

Based on Soros Fund Management's 13F filing for Q1 2018, filed 15 May 2018.